Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Carfilzomib-Based Regiments for the Treatment of Relapsed or Refractory Multiple Myeloma: Single-Center Real-Word Data

Weiwei Zhao, Juan Liu, Liyan Chen, Lianjie Wang, Yanming Xue, Yaoyao Tian, Yao Liu, Xiushuai Dong, Yuying Chang, Xi Chen, Liqian Yu, Xiaomin Zhang, Yinglan Jin, Yan Song, Biqing Han, Dandan Yao, Wei Wang

Blood (2024) 144 (Supplement 1): 7024.

https://doi.org/10.1182/blood-2024-204383

Published: 2024

Journal Articles

Treatment Patterns and Economic Burden Among US Patients with Richter's Syndrome: A Retrospective Claims Analysis

Mahek Garg, Ambika Satija, Yan Song, Ben Meade, James Signorovitch, Shravanthi Gandra

Blood (2024) 144 (Supplement 1): 6470.

https://doi.org/10.1182/blood-2024-208401

Published: 2024

Journal Articles

Targeting Siglec Receptors to Reverse Immune Dysfunction Mediated By Plasmacytoid Dendritic Cells in Multiple Myeloma

Arghya Ray, Leutz Buon, Xueping Wan, Ting Du, Yan Song, Sindhu C Pillai, Md. Abu Musa, Teng Fang, Minxing Wang, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 6825.

https://doi.org/10.1182/blood-2024-205096

Published: 2024

Journal Articles

Economic Burden and Patterns of Care Among Patients with Follicular Lymphoma in the US: A Retrospective Claims Analysis

Mahek Garg, Ambika Satija, Yan Song, Ben Meade, James Signorovitch, Shravanthi Gandra

Blood (2024) 144 (Supplement 1): 6314.

https://doi.org/10.1182/blood-2024-208149

Published: 2024

Journal Articles

A Retrospective Claims Analysis of Real-World Treatment Patterns and Economic Burden Among Patients with Marginal Zone Lymphoma in the US

Mahek Garg, Ambika Satija, Yan Song, Ben Meade, James Signorovitch, Shravanthi Gandra

Blood (2024) 144 (Supplement 1): 5104.

https://doi.org/10.1182/blood-2024-208166

Published: 2024

Journal Articles

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Teng Fang, Yan Song, Ting Du, Arghya Ray, Xueping Wan, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Mu Hao, Lugui Qiu, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1905.

https://doi.org/10.1182/blood-2024-206000

Published: 2024

Journal Articles

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Waldenstrӧm Macroglobulinemia: A Retrospective Analysis of US Claims Data

Mahek Garg, Ambika Satija, Yan Song, Ben Meade, James Signorovitch, Shravanthi Gandra

Blood (2024) 144 (Supplement 1): 3666.

https://doi.org/10.1182/blood-2024-208443

Published: 2024

Journal Articles

Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples

Arghya Ray, Yan Song, Ting Du, Leutz Buon, Md. Abu Musa, Xueping Wan, Sindhu C Pillai, Teng Fang, Minxing Wang, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1947.

https://doi.org/10.1182/blood-2024-204964

Published: 2024

Journal Articles

Proteasome Shuttle Factor and DNA Repair Protein Rad23A Is a Potential Therapeutic Target in Multiple Myeloma

Xueping Wan, Yan Song, Ting Du, Arghya Ray, Teng Fang, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Kenneth Wen, Dharminder Chauhan, Kenneth C. Anderson

Blood (2024) 144 (Supplement 1): 1896.

https://doi.org/10.1182/blood-2024-203535

Published: 2024

Journal Articles

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

Ting Du, Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet K. Samur, Chen Shen, Johany Penailillo, Tomasz Sewastianik, Yu-Tzu Tai, Mariateresa Fulciniti, Nikhil C. Munshi, Hao Wu, Ruben D. Carrasco, Dharminder Chauhan, Kenneth C. Anderson

Blood (2023) 141 (21): 2599–2614.

https://doi.org/10.1182/blood.2022017897

Published: 2023

Includes: Supplemental data

Journal Articles

Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis

Mahek Garg, Ambika Satija, Yan Song, Eric Sarpong, Ben Meade, Esteban Lemus-Wirtz, Katherine Gaburo, James E. Signorovitch, Monika Raut, Katherine Elizabeth Ryland, Samhita Chakraborty

Blood (2022) 140 (Supplement 1): 7920–7921.

https://doi.org/10.1182/blood-2022-162844

Published: 2022

Journal Articles

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel or Other Donor Sources in Patients with Hematologic Malignancies: Comparison of Clinical Trial Results to Center for International Blood and Marrow Transplant Research Database Controls

Smitha Sivaraman, Gautam Sajeev, Yan Song, Chunyi Xu, Chujun He, James E. Signorovitch, Heayoung Shin, Rocio Manghani, Xiao-Ying Tang, Mei-Je Zhang, Linda J Burns, Ronit Simantov

Blood (2022) 140 (Supplement 1): 660–661.

https://doi.org/10.1182/blood-2022-162439

Published: 2022

Journal Articles

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data

Mahek Garg, Ambika Satija, Yan Song, Eric Sarpong, Ben Meade, Esteban Lemus-Wirtz, Katherine Gaburo, James E. Signorovitch, Monika Raut, Katherine Elizabeth Ryland, Samhita Chakraborty

Blood (2022) 140 (Supplement 1): 5075–5076.

https://doi.org/10.1182/blood-2022-162730

Published: 2022

Journal Articles

Patient and Physician Preferences for Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients Not Candidates for Intensive Chemotherapy

Mo Zhou, Hongbo Yang, Yan Song, Deborah A. Marshall, James D. Griffin, Lalit Saini, Manasee V. Shah

Blood (2021) 138 (Supplement 1): 4047.

https://doi.org/10.1182/blood-2021-145385

Published: 2021

Journal Articles

Maintenance Therapy in Patients with FLT3 -ITD-Mutation-Positive Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation: Real-World Survival

Hongbo Yang, Yan Song, James D. Griffin, Manasee V. Shah, Jonathan Freimark, Andrew Chilelli

Blood (2021) 138 (Supplement 1): 693.

https://doi.org/10.1182/blood-2021-145790

Published: 2021

Journal Articles

Ubiquitin Receptor PSMD4/Rpn10 Is a Novel Therapeutic Target in Myeloma

Ting DU, Yan Song, Arghya Ray, Ruben D. Carrasco, Sirano Dhe-Paganon, Dharminder Chauhan, Kenneth C. Anderson

Blood (2021) 138 (Supplement 1): 1591.

https://doi.org/10.1182/blood-2021-151377

Published: 2021

Journal Articles

A High Throughput Quantitative Seroproteomics Analysis of Multiple Myeloma Patients on Tagraxofusp Therapy Identifies Novel Cytokine-Assisted Mechanism of Action

Arghya Ray, PhD, Yan Song, PhD, Ting DU, PhD, Clifton C. Mo, MD, Arturo Olguin, Janice Chen, PhD, Christopher Brooks, PhD, Tariq I. Mughal, MD FRCP, Paul G. Richardson, MD, Dharminder Chauhan, PhD, Kenneth Anderson, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-141571

Published: 2020

Journal Articles

Proteomic Characterization of Ubiquitin Receptor ADRM1/Rpn13

Yan Song, PhD, Ting DU, PhD, Arghya Ray, PhD, Krishan Chauhan, Mehmet K. Samur, PhD, Dharminder Chauhan, PhD, Kenneth Anderson, MD

Blood (2020) 136 (Supplement 1): 39.

https://doi.org/10.1182/blood-2020-139966

Published: 2020

Journal Articles

Blockade of Deubiquitylating Enzyme USP7 in Plasmacytoid Dendritic Cells Stimulates Anti-Myeloma Immunity

Arghya Ray, PhD, Ting DU, PhD, Yan Song, PhD, Sara J Buhrlage, PhD, Dharminder Chauhan, PhD, Kenneth Anderson, MD

Blood (2020) 136 (Supplement 1): 43.

https://doi.org/10.1182/blood-2020-138591

Published: 2020

Journal Articles

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Zhongjun Xia, MDPhD, Su Li, Xiaoqin Chen, MDPhD, Weida Wang, MD PhD, Yan Song

Blood (2020) 136 (Supplement 1): 37.

https://doi.org/10.1182/blood-2020-137346

Published: 2020

NARROW

Efficacy and Safety of Carfilzomib-Based Regiments for the Treatment of Relapsed or Refractory Multiple Myeloma: Single-Center Real-Word Data

Treatment Patterns and Economic Burden Among US Patients with Richter's Syndrome: A Retrospective Claims Analysis

Targeting Siglec Receptors to Reverse Immune Dysfunction Mediated By Plasmacytoid Dendritic Cells in Multiple Myeloma

Economic Burden and Patterns of Care Among Patients with Follicular Lymphoma in the US: A Retrospective Claims Analysis

A Retrospective Claims Analysis of Real-World Treatment Patterns and Economic Burden Among Patients with Marginal Zone Lymphoma in the US

26S Proteasome Non-Atpase Subunit 3 (PSMD3/Rpn3) Is a Potential Therapeutic Target in Multiple Myeloma

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Waldenstrӧm Macroglobulinemia: A Retrospective Analysis of US Claims Data

Full Spectrum Multi-Parameter Single-Tube Flow Cytometry Analysis for Cross-Sectional Immune-Profiling of Natural Killer Cells in Multiple Myeloma Clinical Samples

Proteasome Shuttle Factor and DNA Repair Protein Rad23A Is a Potential Therapeutic Target in Multiple Myeloma

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

Economic Burden and Treatment Patterns Among Patients with Mantle Cell Lymphoma in the US: A Retrospective Claims Analysis

Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel or Other Donor Sources in Patients with Hematologic Malignancies: Comparison of Clinical Trial Results to Center for International Blood and Marrow Transplant Research Database Controls

Real-World Treatment Patterns, Healthcare Resource Use, and Costs Among Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of US Claims Data

Patient and Physician Preferences for Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients Not Candidates for Intensive Chemotherapy

Maintenance Therapy in Patients with FLT3 -ITD-Mutation-Positive Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation: Real-World Survival

Ubiquitin Receptor PSMD4/Rpn10 Is a Novel Therapeutic Target in Myeloma

A High Throughput Quantitative Seroproteomics Analysis of Multiple Myeloma Patients on Tagraxofusp Therapy Identifies Novel Cytokine-Assisted Mechanism of Action

Proteomic Characterization of Ubiquitin Receptor ADRM1/Rpn13

Blockade of Deubiquitylating Enzyme USP7 in Plasmacytoid Dendritic Cells Stimulates Anti-Myeloma Immunity

A Phase 1 Dose-Escalation Study of LH031, a Kinesin Spindle Protein Inhibitor, in Patients with Refractory/Resistance Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only